Trial Profile
Phase I (multiple ascending dose) study with the novel Pseudomonas aeruginosa antibiotic POL7080 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs Murepavadin (Primary)
- Indications Gram-negative infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Jun 2017 Results presented at the ASM Microbe 2017
- 02 May 2012 New trial record